| COVANCE TO PRESENT AT THE UBS WARBURG GLOBAL HEALTHCARE SERVICES CONFERENCE |
 |
Princeton, New Jersey, January 27, 2003 — Covance Inc. (NYSE: CVD) will participate in the UBS Warburg Global Healthcare Services Conference in New York City on Tuesday, February 4, 2003 at 1:30 p.m. EST. Chris Kuebler, Covance's Chairman and Chief Executive Officer, will make a formal presentation at the event.
Covance, with headquarters in Princeton, New Jersey, is one of the world's largest and most comprehensive drug development services companies with 2002 net revenues of $883 million, global operations in 17 countries, and approximately 6,900 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through the website in the About Covance area. |
|
|
